US 11,547,765 · Application 16/787,938 · Granted Jan 10, 2023
US 11,547,765
Optimized mini-dystrophin genes and expression cassettes and their use
Estimated expiration
June 20, 2037
10y 266d remaining
Earliest effective filing
Jun 20, 2017
+ 20 years
Jun 20, 2037
PTA +0d
Jun 20, 2037
No TD
—
Final
Jun 20, 2037
This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.
Calculation details
Base term
- Filing date
- February 11, 2020
- Earliest effective filing
- June 20, 2017
- Issue date
- January 10, 2023
- PTA
- 0 days
- Base expiry (before PTA)
- June 20, 2037
June 20, 2017 + 20 years = June 20, 2037
- Continuation of application 15/628,268, filed Jun 20, 2017
- PRO62/352,675 — Provisional — not used for base term
- PRO62/516,449 — Provisional — not used for base term
- PRO62/352,675 — Provisional — not used for base term
- PRO62/516,449 — Provisional — not used for base term
Terminal disclaimers
Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated
The prosecution record for your AI
Application 16/787,938 · US 11,547,765
You have the date. Your AI can have the file.
PatentReply compiles the prosecution history behind US 11,547,765: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.
One new public application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Permanent link
www.patentreply.ai/tools/patent-expiration/US11547765Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.